1. 119: METASTASECTOMY OR STEREOTACTIC BODY RADIATION THERAPY FOR OLIGOMETASTATIC ESOPHAGOGASTRIC CANCER: A NATIONWIDE POPULATION-BASED COHORT STUDY. (23rd April 2022) Authors: Kroese, T; Jorritsma, N; Haj Mohammad, N; Mook, S; Ruurda, J; Verhoeven, R; Van Rossum, P; Van Laarhoven, H; Van Hillegersberg, R Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 123: SEVERE LYMPHOPENIA ACQUIRED DURING CHEMORADIOTHERAPY FOR ESOPHAGEAL CANCER: INCIDENCE AND EXTERNAL VALIDATION OF A PREDICTION MODEL. (23rd April 2022) Authors: Kroese, T; Jairan, J; Ruurda, J; Lin, S; Mohan, R; Mook, S; Haitjema, S; Hoefer, I; Haj Mohammad, N; Van Hillegersberg, R; Van Rossum, P Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PS02.082: OPTIMAL TIMING FOR ASSESSMENT OF TUMOR RESPONSE TO NCRT WITH MRI IN PATIENTS WITH ESOPHAGEAL CANCER. (14th September 2018) Authors: Borggreve, Alicia; Heethuis, S; Goense, L; Van Rossum, P; Van Lier, A L H M W; Hillegersberg, Richard; Ruurda, Jelle; Lagendijk, J; Mook, Stella; Meijer, G J Journal: Diseases of the esophagus Issue: Volume 31(2018)Supplement 1 Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗